Last reviewed · How we verify

2% Sevoflurane

China International Neuroscience Institution · FDA-approved active Small molecule Quality 5/100

2% Sevoflurane is a Small molecule drug developed by China International Neuroscience Institution. It is currently FDA-approved. Also known as: 2% Sevoflurane continue.

At a glance

Generic name2% Sevoflurane
Also known as2% Sevoflurane continue
SponsorChina International Neuroscience Institution
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about 2% Sevoflurane

What is 2% Sevoflurane?

2% Sevoflurane is a Small molecule drug developed by China International Neuroscience Institution.

Who makes 2% Sevoflurane?

2% Sevoflurane is developed and marketed by China International Neuroscience Institution (see full China International Neuroscience Institution pipeline at /company/china-international-neuroscience-institution).

Is 2% Sevoflurane also known as anything else?

2% Sevoflurane is also known as 2% Sevoflurane continue.

What development phase is 2% Sevoflurane in?

2% Sevoflurane is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing